Widely used:Recently Viewed
Clear All
Value Research Rating
Quality Score 
10/10
Growth Score
7/10
Valuation Score
3/10
Momentum Score
9/10
₹29,472 Cr
77.25
15.46
67.75
0
21.07 %
--
0.68 %
228.06
46
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Dr. Lal Pathlabs
| 36.90 | 4.44 | 20.64 | 42.34 | -1.32 | 21.73 | -- |
|
BSE Healthcare
| 39.69 | 1.64 | 14.63 | 57.51 | 18.93 | 29.52 | 12.37 |
|
BSE Mid Cap
| 30.91 | -0.29 | 1.44 | 52.19 | 23.12 | 28.30 | 17.55 |
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|
|---|---|---|---|---|---|---|---|
|
Dr. Lal Pathlabs
| 14.03 | -40.86 | 58.78 | 50.34 | 61.54 | 2.90 | -17.71 |
|
BSE Mid Cap
| 45.53 | 1.38 | 39.18 | 19.87 | -3.05 | -13.31 | 48.13 |
|
BSE Healthcare
| 36.97 | -12.10 | 20.87 | 61.45 | -3.55 | -5.89 | 0.49 |
|
Stock
|
Peer Median
|
||
|---|---|---|---|
loading... |
|||
|
Stock
|
Peer Median
|
||
|---|---|---|---|
loading... |
|||
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Our rating system has guided millions of investors in the past 20 years.
₹29,472.04 Cr
₹2,287.50 Cr
₹381.50 Cr
₹944.10 Cr
₹83.33 Cr
54.60%
High
₹1,943.70 - 3,653.95
₹10.00
8,35,74,252
BSE: 539524, NSE: LALPATHLAB
New Delhi, Delhi
www.lalpathlabs.com
Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology,... electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers training programs. The company was founded in 1949 and is based in Gurugram, India. Read more
The total asset value of Dr Lal Pathlabs Ltd stood at ₹ 2,456 Cr as on 30-Jun-24
The share price of Dr Lal Pathlabs Ltd is ₹3,528.85 (NSE) and ₹3,526.45 (BSE) as of 10-Oct-2024 15:58 IST. Dr Lal Pathlabs Ltd has given a return of -1.32% in the last 3 years.
Dr Lal Pathlabs Ltd has a market capitalisation of ₹ 29,472 Cr as on 10-Oct-2024. As per Value Research classification, it is a Mid Cap company.
The P/B ratio of Dr Lal Pathlabs Ltd is 15.46 times as on 10-Oct-2024, a 49% premium to its peers’ median range of 10.41 times.
The P/E ratio of Dr Lal Pathlabs Ltd is 77.25 times as on 10-Oct-2024, a 14% premium to its peers’ median range of 67.75 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Dr Lal Pathlabs Ltd and enter the required number of quantities and click on buy to purchase the shares of Dr Lal Pathlabs Ltd.
Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers training programs. The company was founded in 1949 and is based in Gurugram, India.
The promoters of Dr Lal Pathlabs Ltd are Arvind Lal and Vandana Lal. They collectively own 50.54 per cent of the total equity. The chairman of the company is Arvind Lal
There is no promoter pledging in Dr Lal Pathlabs Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
25,965
|
|
|
22,028
|
|
|
11,450
|
|
|
10,149
|
| Dr. Lal Pathlabs Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
21.07
|
|
Operating margin(%)
|
21.42
|
|
Net Margin(%)
|
16.36
|
|
Dividend yield(%)
|
0.68
|
Yes, TTM profit after tax of Dr Lal Pathlabs Ltd was ₹382 Cr.
₹-76.70
